Literature DB >> 33131538

Subsequent Primary Neoplasms: Risks, Risk Factors, Surveillance, and Future Research.

Michael Hawkins1, Smita Bhatia2, Tara O Henderson3, Paul C Nathan4, Adam Yan4, Jop C Teepen5, Lindsay M Morton6.   

Abstract

The authors' objective is to provide a brief update on recent advances in knowledge relating to subsequent primary neoplasms developing in survivors of childhood cancer. This includes a summary of established large-scale cohorts, risks reported, and contrasts with results from recently established large-scale cohorts of survivors of adolescent and young adult cancer. Recent evidence is summarized concerning the role of radiotherapy and chemotherapy for childhood cancer and survivor genomics in determining the risk of subsequent primary neoplasms. Progress with surveillance, screening, and clinical follow-up guidelines is addressed. Finally, priorities for future research are outlined.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Chemotherapy; Follow-up guidelines; Genetic susceptibility; Genetic variation; Radiotherapy; Screening; Second malignant neoplasms; Second primary cancers; Secondary cancers; Subsequent primary neoplasms; Surveillance

Year:  2020        PMID: 33131538     DOI: 10.1016/j.pcl.2020.07.006

Source DB:  PubMed          Journal:  Pediatr Clin North Am        ISSN: 0031-3955            Impact factor:   3.278


  4 in total

Review 1.  Dexrazoxane for preventing or reducing cardiotoxicity in adults and children with cancer receiving anthracyclines.

Authors:  Esmée C de Baat; Renée L Mulder; Saro Armenian; Elizabeth Am Feijen; Heynric Grotenhuis; Melissa M Hudson; Annelies Mc Mavinkurve-Groothuis; Leontien Cm Kremer; Elvira C van Dalen
Journal:  Cochrane Database Syst Rev       Date:  2022-09-27

2.  Cohort-based association study of germline genetic variants with acute and chronic health complications of childhood cancer and its treatment: Genetic Risks for Childhood Cancer Complications Switzerland (GECCOS) study protocol.

Authors:  Nicolas Waespe; Sven Strebel; Tiago Nava; Chakradhara Rao S Uppugunduri; Denis Marino; Veneranda Mattiello; Maria Otth; Fabienne Gumy-Pause; André O Von Bueren; Frederic Baleydier; Luzius Mader; Adrian Spoerri; Claudia E Kuehni; Marc Ansari
Journal:  BMJ Open       Date:  2022-01-24       Impact factor: 2.692

3.  Late Mortality, Subsequent Malignant Neoplasms and Hospitalisations in Long-Term Survivors of Adolescent and Young Adult Hematological Cancers.

Authors:  Annalisa Trama; Claudia Vener; Paolo Lasalvia; Alice Bernasconi
Journal:  Front Oncol       Date:  2022-02-25       Impact factor: 6.244

Review 4.  Second primary malignancies induced by radioactive iodine treatment of differentiated thyroid carcinoma - a critical review and evaluation of the existing evidence.

Authors:  Maximilian J Reinecke; Gerrit Ahlers; Andreas Burchert; Friederike Eilsberger; Glenn D Flux; Robert J Marlowe; Hans-Helge Mueller; Christoph Reiners; Fenja Rohde; Hanneke M van Santen; Markus Luster
Journal:  Eur J Nucl Med Mol Imaging       Date:  2022-03-23       Impact factor: 10.057

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.